Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Climb Bio (CLYM) Share-based Compensation (2020 - 2026)

Climb Bio filings provide 7 years of Share-based Compensation readings, the most recent being $1.6 million for Q1 2026.

  • Quarterly Share-based Compensation fell 20.62% to $1.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.6 million through Mar 2026, up 7.35% year-over-year, with the annual reading at $8.1 million for FY2025, 44.93% up from the prior year.
  • Share-based Compensation hit $1.6 million in Q1 2026 for Climb Bio, up from $1.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $10.2 million in Q1 2023 and bottomed at $465000.0 in Q1 2024.
  • Average Share-based Compensation over 5 years is $2.1 million, with a median of $1.6 million recorded in 2026.
  • The largest annual shift saw Share-based Compensation surged 560.03% in 2023 before it tumbled 95.43% in 2024.
  • Climb Bio's Share-based Compensation stood at $1.9 million in 2022, then plummeted by 36.57% to $1.2 million in 2023, then soared by 37.94% to $1.7 million in 2024, then crashed by 37.09% to $1.0 million in 2025, then soared by 53.88% to $1.6 million in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Share-based Compensation are $1.6 million (Q1 2026), $1.0 million (Q4 2025), and $4.0 million (Q3 2025).